Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $36.1950 (4.37%) ($36.1950 - $36.1950) on Fri. Jun. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 60 | Latest Price | $36.1950(4.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.2% a day on average for past five trading days. | Weekly Trend | HALO advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(31%) IWO(29%) IBB(28%) IWM(28%) CEMB(27%) | Factors Impacting HALO price | HALO will decline at least -1.345% in a week (0% probabilities). UUP(-22%) TBT(-21%) EDOC(-12%) INDA(-10%) IGOV(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 2.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $34.84(3.89%) | 10 Day Moving Average | $34.99(3.44%) | 20 Day Moving Average | $34.44(5.1%) | To recent high | -6.4% | To recent low | 20% | Market Cap | $4.947b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |